Biol Reprod
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

BOR - Papers in Press, published online ahead of print October 17, 2002.
Biol Reprod 2002, 10.1095/biolreprod.102.007633
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
68/2/370    most recent
biolreprod.102.007633v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roselli, C. E.
Right arrow Articles by Stormshak, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roselli, C. E.
Right arrow Articles by Stormshak, F.
Agricola
Right arrow Articles by Roselli, C. E.
Right arrow Articles by Stormshak, F.
BIOLOGY OF REPRODUCTION 68, 370–374 (2003)
DOI: 10.1095/biolreprod.102.007633
© 2003 by the Society for the Study of Reproduction, Inc.

Neuroendocrinology

Estrogen Synthesis in Fetal Sheep Brain: Effect of Maternal Treatment with an Aromatase Inhibitor1

Charles E. Roselli2,a, John A. Reskoa, and Fredrick Stormshakb

a Department of Physiology and Pharmacology, Oregon Health & Science University, Portland, Oregon 97201-3098 b Department of Animal Sciences, Oregon State University, Corvallis, Oregon 97331-6702

The aim of the present study was to determine whether the fetal lamb brain has the capacity to aromatize androgens to estrogens during the critical period for sexual differentiation. We also determined whether administration of the aromatase-inhibitor 1,4,6-androstatriene-3,17-dione (ATD) could cross the placenta and inhibit aromatase activity (AA) in fetal brain. Eight pregnant ewes were utilized. On Day 50 of pregnancy, four ewes were given ATD-filled Silastic implants, and the other four ewes received sham surgeries. The fetuses were surgically delivered 2 wk later (Day 64 of gestation). High levels of AA (0.8–1.4 pmol/h/mg protein) were present in the hypothalamus and amygdala. Lower levels (0.02–0.1 pmol/h/mg protein) were measured in brain stem regions, cortex, and olfactory bulbs. The Michaelis-Menten dissociation constant (Km) for aromatase in the fetal sheep brain was 3–4 nM. No significant sex differences in AA were observed in brain. Treatment with ATD produced significant inhibition of AA in most brain areas but did not significantly alter serum profiles of the major sex steroids in maternal and fetal serum. Concentrations of testosterone in serum from the umbilical artery and vein were significantly greater in male than in female fetuses. No other sex differences in serum steroids were observed. These data demonstrate that high levels of AA are found in the fetal sheep hypothalamus and amygdala during the critical period for sexual differentiation. They also demonstrate that AA can be inhibited in the fetal lamb brain by treating the mother with ATD, without harming fetal development.

1 Supported by NIH grant RR14270 (C.E.R.).

2 Correspondence: Charles E. Roselli, Department of Physiology and Pharmacology L334, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97201-3098. FAX: 503 494 4352; rosellic{at}ohsu.edu






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Society for the Study of Reproduction.